Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Aberrant crypt foci in the adenoma prevention with celecoxib trialNancy L Cho, Mark Redston, Ann G Zauber, et al.
The Journal of Nutrition|March 18, 2000
Progress in cancer chemoprevention: development of diet-derived chemopreventive agentsG J Kelloff, J A Crowell, V E Steele, et al.
Annals of the New York Academy of Sciences|February 11, 2000
Progress in cancer chemopreventionG J Kelloff, J A Crowell, V E Steele, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2020
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional studyHarrys A Torres, Anna S Lok, Maria E Suarez-Almazor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 22, 2021
Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas HispanicsJingjing Jiao, Suet-Ying Kwan, Caroline M Sabotta, et al.
Angewandte Chemie (International Ed. in English)|January 26, 2019
Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance SpectroscopyNiki M Zacharias, Argentina Ornelas, Jaehyuk Lee, et al.
Hepatology (Baltimore, Md.)|October 11, 2021
Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver diseaseSuet-Ying Kwan, Jingjing Jiao, Aron Joon, et al.
Gastroenterology|September 7, 2005
Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxibPaul J Limburg, Wenqiang Wei, Dennis J Ahnen, et al.
Pageof 18